{"id":"https://openalex.org/W4281648792","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.602","title":"Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.","display_name":"Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281648792","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.602"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.602","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010278367","display_name":"Sherene Loi","orcid":"https://orcid.org/0000-0001-6137-9171","observed_orcids":["https://orcid.org/0000-0001-6137-9171"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sherene Loi","raw_affiliation_strings":["Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027201197","display_name":"Prudence A. Francis","orcid":"https://orcid.org/0000-0002-7207-9286","observed_orcids":["https://orcid.org/0000-0002-7207-9286"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Prudence A. Francis","raw_affiliation_strings":["Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021313237","display_name":"Nicholas Zdenkowski","orcid":"https://orcid.org/0000-0001-8738-8463","observed_orcids":["https://orcid.org/0000-0001-8738-8463"]},"institutions":[{"id":"https://openalex.org/I4210092896","display_name":"Breast Cancer Trials","ror":"https://ror.org/00j1vsg87","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210092896"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Nicholas Zdenkowski","raw_affiliation_strings":["Breast Cancer Trials - Australia and New Zealand, Newcastle, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Trials - Australia and New Zealand, Newcastle, NSW, Australia;","institution_ids":["https://openalex.org/I4210092896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023743013","display_name":"Val Gebski","orcid":"https://orcid.org/0000-0001-8748-1844","observed_orcids":["https://orcid.org/0000-0001-8748-1844"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Val Gebski","raw_affiliation_strings":["NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia;","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088637763","display_name":"Stephen B. Fox","orcid":"https://orcid.org/0000-0002-7648-8896","observed_orcids":["https://orcid.org/0000-0002-7648-8896"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Stephen B. Fox","raw_affiliation_strings":["Peter MacCallum Cancer Centre, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, Melbourne, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008109491","display_name":"Michelle Ann White","orcid":"https://orcid.org/0000-0002-4037-0722","observed_orcids":["https://orcid.org/0000-0002-4037-0722"]},"institutions":[{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michelle White","raw_affiliation_strings":["Monash Health, Clayton, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash Health, Clayton, VIC, Australia;","institution_ids":["https://openalex.org/I4210121067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010568205","display_name":"Belinda Emma Kiely","orcid":"https://orcid.org/0000-0002-1662-3523","observed_orcids":["https://orcid.org/0000-0002-1662-3523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Belinda Emma Kiely","raw_affiliation_strings":["Macarthur Cancer Therapy Centre, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Macarthur Cancer Therapy Centre, Sydney, Australia;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027481104","display_name":"Natasha E. Woodward","orcid":"https://orcid.org/0000-0003-0944-4807","observed_orcids":["https://orcid.org/0000-0003-0944-4807"]},"institutions":[{"id":"https://openalex.org/I1316052090","display_name":"Mater Health Services","ror":"https://ror.org/03mjtdk61","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1316052090"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Natasha E. Woodward","raw_affiliation_strings":["Mater Cancer Care Centre - Mater Health Services, South Brisbane, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mater Cancer Care Centre - Mater Health Services, South Brisbane, Australia;","institution_ids":["https://openalex.org/I1316052090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004864286","display_name":"Rina Hui","orcid":"https://orcid.org/0000-0003-0696-7442","observed_orcids":["https://orcid.org/0000-0003-0696-7442"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rina Hui","raw_affiliation_strings":["Westmead Breast Cancer Institute, Westmead Hospital and the University of Sydney, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westmead Breast Cancer Institute, Westmead Hospital and the University of Sydney, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004957581","display_name":"Andrew David Redfern","orcid":"https://orcid.org/0000-0001-6728-8713","observed_orcids":["https://orcid.org/0000-0001-6728-8713"]},"institutions":[{"id":"https://openalex.org/I2800728469","display_name":"Fiona Stanley Hospital","ror":"https://ror.org/027p0bm56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800728469","https://openalex.org/I2800882159","https://openalex.org/I4388446375","https://openalex.org/I4388482742"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew David Redfern","raw_affiliation_strings":["Fiona Stanley Hospital, Murdoch, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fiona Stanley Hospital, Murdoch, Australia;","institution_ids":["https://openalex.org/I2800728469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087705142","display_name":"Raewyn Calvert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092896","display_name":"Breast Cancer Trials","ror":"https://ror.org/00j1vsg87","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210092896"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Raewyn Calvert","raw_affiliation_strings":["Breast Cancer Trials - Australia and New Zealand, Newcastle, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Trials - Australia and New Zealand, Newcastle, NSW, Australia;","institution_ids":["https://openalex.org/I4210092896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078658265","display_name":"Lauren Rennie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092896","display_name":"Breast Cancer Trials","ror":"https://ror.org/00j1vsg87","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210092896"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Lauren Rennie","raw_affiliation_strings":["Breast Cancer Trials, Newcastle, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Trials, Newcastle, NSW, Australia;","institution_ids":["https://openalex.org/I4210092896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072172554","display_name":"Frances M. Boyle","orcid":"https://orcid.org/0000-0003-3798-1570","observed_orcids":["https://orcid.org/0000-0003-3798-1570","https://orcid.org/0000-0003-1665-2137"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Frances M. Boyle","raw_affiliation_strings":["University of Sydney and Mater Hospital, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sydney and Mater Hospital, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"last","author":{"id":null,"display_name":"Breast Cancer Trials-Australia and New Zealand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Breast Cancer Trials-Australia and New Zealand","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"602","last_page":"602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.025200000032782555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-immunotherapy","display_name":"neoadjuvant immunotherapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9919999837875366},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9100000262260437},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7829999923706055},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9259999990463257},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6150000095367432},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.4449999928474426},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.6430000066757202},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8730000257492065},{"id":"https://openalex.org/keywords/axillary-lymph-node-response","display_name":"axillary lymph node response","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9270652532577515},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.748859167098999},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6705800294876099},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6535148620605469},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6315093040466309},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6301400661468506},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5743768215179443},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5077251195907593},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48369723558425903},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.4699927568435669},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4455033838748932},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.42409029603004456},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41932910680770874},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4137977361679077},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.41017451882362366},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40763527154922485},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3603890538215637},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2843531668186188},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.08983904123306274},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.602","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401331679","https://openalex.org/W3087393791","https://openalex.org/W4390577309","https://openalex.org/W4365816066","https://openalex.org/W4410809158","https://openalex.org/W4416827174","https://openalex.org/W4410809112","https://openalex.org/W2889939378","https://openalex.org/W7162650967","https://openalex.org/W4411290601"],"abstract_inverted_index":{"602":[0],"Background:":[1],"We":[2],"examined":[3],"the":[4,152,167,193,226,273,284,297,343,359,391,412],"efficacy":[5],"and":[6,11,52,106,145,174,182,257,293,318,334,396,416,425],"safety":[7],"of":[8,58,63,73,302,394,402,414,429,433],"neoadjuvant":[9,97,360,419],"ipilimumab":[10,98,415],"nivolumab":[12,107,417],"combined":[13],"with":[14,24,46,65,115,147,265,304,339,388],"paclitaxel":[15,117,420],"following":[16],"suboptimal":[17,77,153,239,266,298],"response":[18,78,141,165,268],"to":[19,55,418],"anthracycline-based":[20,74,93,224],"chemotherapy":[21],"in":[22,38,88,143,151,156,166,250,255,260,283,289,296,422],"patients":[23,37,159,186,203,264,292,303,338,364],"early-stage":[25],"TNBC.":[26],"Methods:":[27],"This":[28],"single":[29],"arm":[30],"multicentre":[31],"phase":[32],"2":[33,104,110,381],"study":[34,221],"enrolled":[35],"34":[36,185],"8":[39,312],"sites.":[40],"Patients":[41,95],"were":[42,53,187,190,204,212,217,237,437],"aged":[43],"\u226518":[44],"years":[45],"previously":[47],"untreated":[48],"stage":[49,206],"3":[50,404],"TNBC":[51],"required":[54],"have":[56],"\u226515mm":[57],"tumor":[59,64,89,228,271],"remaining":[60],"or":[61,380],"10mm":[62],"one":[66,368,400],"positive":[67,158],"lymph":[68],"node":[69,213],"after":[70,91,390],"4":[71],"cycles":[72],"therapy.":[75],"A":[76],"subset":[79],"at":[80,118,332,366],"baseline":[81],"was":[82,138,198,232,245,276,286,311,330,349,354,377,399],"defined":[83],"as":[84],"<":[85],"50%":[86,270],"reduction":[87],"volume":[90],"initial":[92],"chemotherapy.":[94],"received":[96],"1mg/kg":[99],"IV":[100],"6":[101,113],"weekly":[102,116],"for":[103,112,120,132,192,347],"doses":[105],"240mg":[108],"every":[109],"weeks":[111],"doses,":[114],"80mg/m2":[119],"12":[121,351],"weeks,":[122],"followed":[123],"by":[124,161,170,230],"surgery.":[125],"Nivolumab":[126],"(480mg":[127],"4-weekly)":[128],"continued":[129],"post":[130],"operatively":[131],"further":[133],"9":[134],"months.":[135],"Primary":[136],"endpoint":[137],"pathological":[139],"complete":[140],"(pCR)":[142],"breast":[144,168,285],"axilla,":[146],"secondary":[148],"endpoints":[149],"pCR":[150,155,242,274,340,426],"responders,":[154],"PD-L1":[157,218,430],"(\u22651%":[160],"SP142":[162],"assay),":[163],"clinical":[164,205],"(ORR":[169],"RECIST),":[171],"event-free":[172],"(EFS)":[173],"overall":[175],"survival":[176],"(OS).":[177],"Results:":[178],"Between":[179],"December":[180],"2018":[181],"April":[183],"2020,":[184],"enrolled,":[188],"33":[189],"evaluable":[191,291],"primary":[194],"endpoint.":[195],"Median":[196],"age":[197],"46.6yrs.":[199],"At":[200,220],"diagnosis,":[201],"all":[202,251,290],"III":[207],"(AJCC":[208],"v8),":[209],"16/34":[210],"(47%)":[211],"positive,":[214],"8/31":[215],"(26%)":[216],"positive.":[219],"entry":[222],"(following":[223],"chemo),":[225],"median":[227,325],"size":[229],"ultrasound":[231],"28mm":[233],"(12-62).":[234],"16/33":[235],"(48%)":[236],"considered":[238],"responders.":[240,299],"The":[241,300],"rate":[243,275],"(ypT0ypN0)":[244],"24.2%":[246],"(95%":[247,278],"CI,":[248,279],"11.09-42.26)":[249],"evaluable,":[252],"37.5%":[253],"[3/11]":[254],"PD-L1+":[256],"23%":[258],"[5/22]":[259],"PD-L1-":[261],"patients.":[262],"In":[263,358,407],"anthracycline":[267],"(<":[269],"reduction),":[272],"18.8%":[277],"8.52-75.51)":[280],"(3/16).":[281],"ORR":[282,424],"57.6%":[287],"(19/33)":[288],"43.7%":[294],"(8/20)":[295],"number":[301],"residual":[305],"cancer":[306],"burden":[307],"(RCB)":[308],"class":[309],"0,1,2,3":[310],"(24%),":[313],"1":[314,379],"(3%),":[315],"19":[316],"(57.5%)":[317],"5":[319],"(15%)":[320],"respectively.":[321],"With":[322],"14":[323],"months":[324],"follow":[326],"up,":[327],"12-months":[328],"EFS":[329,348,353],"estimated":[331],"85%":[333],"OS":[335],"94%.":[336],"For":[337],"vs":[341,356],"non-pCR,":[342],"hazard":[344],"ratio":[345],"(HR)":[346],"0.62,":[350],"mo":[352],"100%":[355],"75%.":[357],"phase,":[361],"15/33":[362],"(45%)":[363],"experienced":[365],"least":[367],"grade":[369,378,403,435],"3-4":[370],"adverse":[371],"event.":[372],"Most":[373],"common":[374],"immune-related":[375],"event":[376],"pneumonitis":[382,436],"9/33":[383],"(27%),":[384],"which":[385],"generally":[386],"occurred":[387],"fever":[389],"first":[392],"dose":[393],"ipilimumab,":[395],"resolved.":[397],"There":[398],"case":[401],"colitis.":[405],"Conclusions:":[406],"these":[408],"high":[409],"risk":[410],"patients,":[411],"addition":[413],"resulted":[421],"promising":[423],"rates,":[427],"regardless":[428],"status.":[431],"Rates":[432],"low":[434],"high.":[438],"Follow":[439],"up":[440],"continues.":[441],"Clinical":[442],"trial":[443],"information:":[444],"ACTRN12617000651381.":[445]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-06-13T00:00:00"}